S&P ASX All Technology

US Dollar vs AUD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

TRML Tourmaline Bio Inc

17.93

-0.07 (-0.39%)

Last Updated: 03:18:41

Delayed by 15 minutes

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

null

Tourmaline Bio (NASDAQ:TRML)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more Tourmaline Bio Charts.

Tourmaline Bio (NASDAQ:TRML)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more Tourmaline Bio Charts.

Tourmaline Bio Inc News

Tourmaline Strengthens Cardiovascular Scientific Advisory Board with Appointment of Dr. Paul M. Ridker
Friday 10 January 2025 (2 weeks ago) • GlobeNewswire Inc.

Form 8-K - Current report
Wednesday 11 December 2024 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 11 December 2024 (1 month ago) • Edgar (US Regulatory)

Tourmaline Bio Highlights Cardiovascular Inflammation Focus and Announces Key Clinical and Strategic Updates at Investor Day
Wednesday 11 December 2024 (1 month ago) • GlobeNewswire Inc.

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Friday 15 November 2024 (2 months ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Friday 15 November 2024 (2 months ago) • Edgar (US Regulatory)

Tourmaline Bio to Host Investor Day on Tuesday, December 10, 2024
Thursday 14 November 2024 (2 months ago) • GlobeNewswire Inc.

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Saturday 9 November 2024 (2 months ago) • Edgar (US Regulatory)

Form S-3 - Registration statement under Securities Act of 1933
Friday 8 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Friday 8 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 7 November 2024 (2 months ago) • Edgar (US Regulatory)

Tourmaline Bio Reports Third Quarter 2024 Financial Results and Recent Business Highlights
Thursday 7 November 2024 (2 months ago) • GlobeNewswire Inc.

More Tourmaline Bio Inc News Articles

Melco Resorts & Entertai...

Vontobel Financial Produ...

Societe Generale Effekten

LOJAS MARISA ON

Índice Bovespa

WisdomTree Commodity Sec...

Australia SSA Bonds UCIT...

Societe Generale Effekten

Societe Generale Effekten

Societe Generale Effekten

Societe Generale Effekten

Biomarin Phar Dl 001

Credit Agricole

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions